Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLI vs MRNA✓SelectedUSD · MRNAXLI vs MRNA performance historyLatest closeAs of-3.09%11/20
Stock and ETF performance explorer

XLI vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-7.9%
MRNA return
+323.5%
Excess return
-331.5%
Maximum drawdown
-15.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.1%-2.2%-0.9%-3.1%
7D-7.4%-12.7%+5.3%-7.3%
30D-7.1%-20.7%+13.6%-7.1%
3M-12.8%+46.3%-59.0%-12.7%
6M-7.9%+305.2%-313.2%-10.7%
All-7.9%+323.5%-331.5%-10.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling